Literature DB >> 17924119

Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.

Patric Kröpil1, Roland Fenk, Lars B Fritz, Dirk Blondin, Guido Kobbe, Ulrich Mödder, Mathias Cohnen.   

Abstract

This study compares the sensitivity of whole-body multidetector CT (MDCT) and conventional radiography (CR) in the staging of multiple myeloma (MM). Twenty-nine patients with MM underwent a staging examination both by MDCT and CR. CT examination was performed with a collimation of 64x0.6 mm, a tube potential of 100 kVp, an effective tube current-time product of 100 mAs and automatic dose modulation as low-dose protocol. Number, size and diagnostic confidence of osteolytic lesions were determined and compared. The effective dose of MDCT and CR was assessed. Using MDCT, the detection of osteolysis was increased seven-fold concerning the spine. Ninety-seven lesions in 18 patients were detected exclusively by MDCT. The detection rate concerning the spine, pelvic skeleton and thoracic cage was significantly higher (p< or =0.001), and diagnostic confidence was increased by MDCT (p<0.02) compared to CR. Therapy was changed after MDCT in 18.2% of the patients with a clinical suspicion of progressive disease. The estimated effective dose of MDCT (4.8 mSv) and CR (1.7 mSv) was comparable. In conclusion, MDCT has a significantly higher sensitivity and reliability in the detection of osteolysis than CR and can be recommended as standard imaging method in the staging of MM.

Entities:  

Mesh:

Year:  2007        PMID: 17924119     DOI: 10.1007/s00330-007-0738-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Use of an automatic exposure control mechanism for dose optimization in multi-detector row CT examinations: clinical evaluation.

Authors:  Tom H Mulkens; Patrick Bellinck; Michel Baeyaert; Dirk Ghysen; Xavier Van Dijck; Elvier Mussen; Caroline Venstermans; Jean-Luc Termote
Journal:  Radiology       Date:  2005-08-26       Impact factor: 11.105

2.  Evaluation of dose exposure in 64-slice CT colonography.

Authors:  O Luz; M Buchgeister; M Klabunde; T Trabold; A F Kopp; C D Claussen; M Heuschmid
Journal:  Eur Radiol       Date:  2007-02-07       Impact factor: 5.315

3.  Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.

Authors:  A Stäbler; A Baur; R Bartl; R Munker; R Lamerz; M F Reiser
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

Review 4.  Staging and kinetics of multiple myeloma.

Authors:  B G Durie
Journal:  Semin Oncol       Date:  1986-09       Impact factor: 4.929

5.  Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.

Authors:  Marius Horger; Claus D Claussen; Ulrike Bross-Bach; Reinhard Vonthein; Tobias Trabold; Martin Heuschmid; Christina Pfannenberg
Journal:  Eur J Radiol       Date:  2005-05       Impact factor: 3.528

6.  Comparison of CT, MRI, and radiographs in assessing pelvic osteolysis: a cadaveric study.

Authors:  Tim A Walde; Daniel E Weiland; Serena B Leung; Nobuto Kitamura; Christi J Sychterz; C Anderson Engh; Alexandra M Claus; Hollis G Potter; Charles A Engh
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

7.  Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.

Authors:  Cristina Nanni; Elena Zamagni; Mohsen Farsad; Paolo Castellucci; Patrizia Tosi; Delia Cangini; Eugenio Salizzoni; Romeo Canini; Michele Cavo; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-02       Impact factor: 9.236

Review 8.  Diagnosis, prognosis, and standard treatment of multiple myeloma.

Authors:  M Boccadoro; A Pileri
Journal:  Hematol Oncol Clin North Am       Date:  1997-02       Impact factor: 3.722

9.  Multiple myeloma: early vertebral involvement assessed by computerised tomography.

Authors:  A Solomon; R Rahamani; U Seligsohn; F Ben-Artzi
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

10.  Comparison between low-dose and standard-dose multidetector CT in patients with suspected chronic sinusitis.

Authors:  Denis Tack; Jacques Widelec; Viviane De Maertelaer; Jean-Marie Bailly; Christian Delcour; Pierre Alain Gevenois
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

View more
  43 in total

Review 1.  Advanced imaging of skeletal manifestations of systemic mastocytosis.

Authors:  J Fritz; E K Fishman; J A Carrino; M S Horger
Journal:  Skeletal Radiol       Date:  2012-02-26       Impact factor: 2.199

Review 2.  The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

Authors:  Jo Caers; Nadia Withofs; Jens Hillengass; Paolo Simoni; Elena Zamagni; Roland Hustinx; Yves Beguin
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

3.  Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images.

Authors:  Georg Homann; Katja Weisel; Deedar Farhad Mustafa; Hendrik Ditt; Konstantin Nikolaou; Marius Horger
Journal:  Skeletal Radiol       Date:  2015-04-02       Impact factor: 2.199

4.  Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.

Authors:  F Joseph Simeone; Joel P Harvey; Andrew J Yee; Elizabeth K O'Donnell; Noopur S Raje; Martin Torriani; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2018-09-14       Impact factor: 2.199

Review 5.  Minimal residual disease testing after stem cell transplantation for multiple myeloma.

Authors:  A M Sherrod; P Hari; C A Mosse; R C Walker; R F Cornell
Journal:  Bone Marrow Transplant       Date:  2015-07-20       Impact factor: 5.483

6.  Impact of organ-specific dose reduction on the image quality of head and neck CT angiography.

Authors:  L Schimmöller; R S Lanzman; P Heusch; S Dietrich; F Miese; J Aissa; T A Heusner; G Antoch; P Kröpil
Journal:  Eur Radiol       Date:  2013-01-09       Impact factor: 5.315

Review 7.  Diagnostic Advances in Multiple Myeloma.

Authors:  Kevin Barley; Ajai Chari
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

Review 8.  Imaging in myeloma with focus on advanced imaging techniques.

Authors:  Tara Barwick; Laure Bretsztajn; Kathryn Wallitt; Dimitri Amiras; Andrea Rockall; Christina Messiou
Journal:  Br J Radiol       Date:  2019-01-03       Impact factor: 3.039

Review 9.  Myeloma and Bone Disease.

Authors:  Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 10.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.